nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Ageusia—Cisplatin—esophageal cancer	0.0145	0.0216	CcSEcCtD
Glycopyrrolate—Infection—Carboplatin—esophageal cancer	0.0142	0.0211	CcSEcCtD
Glycopyrrolate—Intestinal obstruction—Capecitabine—esophageal cancer	0.0127	0.0189	CcSEcCtD
Glycopyrrolate—Pain—Carboplatin—esophageal cancer	0.0122	0.0182	CcSEcCtD
Glycopyrrolate—Ventricular fibrillation—Capecitabine—esophageal cancer	0.0113	0.0168	CcSEcCtD
Glycopyrrolate—Body temperature increased—Carboplatin—esophageal cancer	0.0113	0.0168	CcSEcCtD
Glycopyrrolate—Ageusia—Capecitabine—esophageal cancer	0.0107	0.0159	CcSEcCtD
Glycopyrrolate—Nasal congestion—Cisplatin—esophageal cancer	0.00934	0.0139	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00879	0.0131	CcSEcCtD
Glycopyrrolate—Injection site reaction—Capecitabine—esophageal cancer	0.00859	0.0128	CcSEcCtD
Glycopyrrolate—Irritability—Cisplatin—esophageal cancer	0.00812	0.0121	CcSEcCtD
Glycopyrrolate—Dehydration—Cisplatin—esophageal cancer	0.00791	0.0118	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Cisplatin—esophageal cancer	0.00761	0.0114	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Capecitabine—esophageal cancer	0.00708	0.0106	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Cisplatin—esophageal cancer	0.00705	0.0105	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Capecitabine—esophageal cancer	0.00662	0.00988	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Methotrexate—esophageal cancer	0.00628	0.00938	CcSEcCtD
Glycopyrrolate—Pain in extremity—Capecitabine—esophageal cancer	0.00627	0.00936	CcSEcCtD
Glycopyrrolate—Cystitis—Methotrexate—esophageal cancer	0.00621	0.00927	CcSEcCtD
Glycopyrrolate—Irritability—Capecitabine—esophageal cancer	0.00599	0.00894	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Capecitabine—esophageal cancer	0.00597	0.0089	CcSEcCtD
Glycopyrrolate—Urinary retention—Capecitabine—esophageal cancer	0.00597	0.0089	CcSEcCtD
Glycopyrrolate—Mood swings—Capecitabine—esophageal cancer	0.00594	0.00887	CcSEcCtD
Glycopyrrolate—Dehydration—Capecitabine—esophageal cancer	0.00583	0.00871	CcSEcCtD
Glycopyrrolate—Bladder pain—Methotrexate—esophageal cancer	0.00582	0.00868	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Cisplatin—esophageal cancer	0.00581	0.00868	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Cisplatin—esophageal cancer	0.00579	0.00864	CcSEcCtD
Glycopyrrolate—Urethral disorder—Cisplatin—esophageal cancer	0.00577	0.00861	CcSEcCtD
Glycopyrrolate—Dry skin—Capecitabine—esophageal cancer	0.00575	0.00858	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Capecitabine—esophageal cancer	0.00561	0.00837	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Cisplatin—esophageal cancer	0.00546	0.00816	CcSEcCtD
Glycopyrrolate—Flushing—Cisplatin—esophageal cancer	0.00546	0.00816	CcSEcCtD
Glycopyrrolate—Abdominal distension—Capecitabine—esophageal cancer	0.00546	0.00815	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00531	0.00792	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Capecitabine—esophageal cancer	0.0052	0.00776	CcSEcCtD
Glycopyrrolate—Malnutrition—Cisplatin—esophageal cancer	0.00513	0.00765	CcSEcCtD
Glycopyrrolate—Erythema—Cisplatin—esophageal cancer	0.00513	0.00765	CcSEcCtD
Glycopyrrolate—Dysuria—Capecitabine—esophageal cancer	0.00507	0.00757	CcSEcCtD
Glycopyrrolate—Flatulence—Cisplatin—esophageal cancer	0.00505	0.00754	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00504	0.00752	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Capecitabine—esophageal cancer	0.00489	0.0073	CcSEcCtD
Glycopyrrolate—Pneumonia—Capecitabine—esophageal cancer	0.00486	0.00726	CcSEcCtD
Glycopyrrolate—Infestation NOS—Capecitabine—esophageal cancer	0.00483	0.00722	CcSEcCtD
Glycopyrrolate—Infestation—Capecitabine—esophageal cancer	0.00483	0.00722	CcSEcCtD
Glycopyrrolate—Vision blurred—Cisplatin—esophageal cancer	0.00483	0.00721	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00483	0.0072	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Capecitabine—esophageal cancer	0.0047	0.00701	CcSEcCtD
Glycopyrrolate—Epistaxis—Capecitabine—esophageal cancer	0.00456	0.00681	CcSEcCtD
Glycopyrrolate—Irritability—Methotrexate—esophageal cancer	0.00446	0.00665	CcSEcCtD
Glycopyrrolate—Convulsion—Cisplatin—esophageal cancer	0.00444	0.00663	CcSEcCtD
Glycopyrrolate—Mood swings—Methotrexate—esophageal cancer	0.00442	0.0066	CcSEcCtD
Glycopyrrolate—Rhinitis—Capecitabine—esophageal cancer	0.00435	0.00649	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00433	0.00647	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Capecitabine—esophageal cancer	0.00432	0.00645	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Capecitabine—esophageal cancer	0.00429	0.0064	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Capecitabine—esophageal cancer	0.00426	0.00637	CcSEcCtD
Glycopyrrolate—Urethral disorder—Capecitabine—esophageal cancer	0.00425	0.00635	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Cisplatin—esophageal cancer	0.00418	0.00624	CcSEcCtD
Glycopyrrolate—Oedema—Cisplatin—esophageal cancer	0.00418	0.00624	CcSEcCtD
Glycopyrrolate—Infection—Cisplatin—esophageal cancer	0.00416	0.0062	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Cisplatin—esophageal cancer	0.0041	0.00612	CcSEcCtD
Glycopyrrolate—Tachycardia—Cisplatin—esophageal cancer	0.00408	0.00609	CcSEcCtD
Glycopyrrolate—Skin disorder—Cisplatin—esophageal cancer	0.00406	0.00606	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00404	0.00604	CcSEcCtD
Glycopyrrolate—Flushing—Capecitabine—esophageal cancer	0.00403	0.00601	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Capecitabine—esophageal cancer	0.00403	0.00601	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00391	0.00584	CcSEcCtD
Glycopyrrolate—Hypotension—Cisplatin—esophageal cancer	0.00391	0.00583	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—esophageal cancer	0.00387	0.00578	CcSEcCtD
Glycopyrrolate—Mental disorder—Capecitabine—esophageal cancer	0.0038	0.00568	CcSEcCtD
Glycopyrrolate—Erythema—Capecitabine—esophageal cancer	0.00378	0.00564	CcSEcCtD
Glycopyrrolate—Malnutrition—Capecitabine—esophageal cancer	0.00378	0.00564	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—esophageal cancer	0.00377	0.00563	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00375	0.0056	CcSEcCtD
Glycopyrrolate—Flatulence—Capecitabine—esophageal cancer	0.00372	0.00556	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—esophageal cancer	0.00372	0.00555	CcSEcCtD
Glycopyrrolate—Dysgeusia—Capecitabine—esophageal cancer	0.0037	0.00552	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—esophageal cancer	0.00362	0.0054	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00361	0.00539	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—esophageal cancer	0.0036	0.00537	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—esophageal cancer	0.0036	0.00537	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—esophageal cancer	0.0036	0.00537	CcSEcCtD
Glycopyrrolate—Pain—Cisplatin—esophageal cancer	0.00358	0.00534	CcSEcCtD
Glycopyrrolate—Vision blurred—Capecitabine—esophageal cancer	0.00356	0.00531	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—esophageal cancer	0.00345	0.00515	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Cisplatin—esophageal cancer	0.00345	0.00515	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—esophageal cancer	0.00339	0.00507	CcSEcCtD
Glycopyrrolate—Palpitations—Capecitabine—esophageal cancer	0.00334	0.00498	CcSEcCtD
Glycopyrrolate—Body temperature increased—Cisplatin—esophageal cancer	0.00331	0.00494	CcSEcCtD
Glycopyrrolate—Hypertension—Capecitabine—esophageal cancer	0.00326	0.00487	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00319	0.00477	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—esophageal cancer	0.00319	0.00476	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—esophageal cancer	0.00317	0.00473	CcSEcCtD
Glycopyrrolate—Dry mouth—Capecitabine—esophageal cancer	0.00315	0.0047	CcSEcCtD
Glycopyrrolate—Confusional state—Capecitabine—esophageal cancer	0.00311	0.00464	CcSEcCtD
Glycopyrrolate—Oedema—Capecitabine—esophageal cancer	0.00308	0.0046	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Cisplatin—esophageal cancer	0.00308	0.0046	CcSEcCtD
Glycopyrrolate—Infection—Capecitabine—esophageal cancer	0.00306	0.00457	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Capecitabine—esophageal cancer	0.00302	0.00451	CcSEcCtD
Glycopyrrolate—Tachycardia—Capecitabine—esophageal cancer	0.00301	0.00449	CcSEcCtD
Glycopyrrolate—Asthenia—Cisplatin—esophageal cancer	0.003	0.00448	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—esophageal cancer	0.003	0.00448	CcSEcCtD
Glycopyrrolate—Skin disorder—Capecitabine—esophageal cancer	0.00299	0.00447	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00298	0.00445	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—esophageal cancer	0.00291	0.00435	CcSEcCtD
Glycopyrrolate—Hypotension—Capecitabine—esophageal cancer	0.00288	0.0043	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—esophageal cancer	0.00283	0.00422	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—esophageal cancer	0.00281	0.0042	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—esophageal cancer	0.00281	0.0042	CcSEcCtD
Glycopyrrolate—Insomnia—Capecitabine—esophageal cancer	0.00279	0.00416	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—esophageal cancer	0.00275	0.00411	CcSEcCtD
Glycopyrrolate—Dyspepsia—Capecitabine—esophageal cancer	0.00271	0.00405	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00266	0.00397	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—esophageal cancer	0.00266	0.00397	CcSEcCtD
Glycopyrrolate—Fatigue—Capecitabine—esophageal cancer	0.00266	0.00397	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—esophageal cancer	0.00265	0.00396	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—esophageal cancer	0.00264	0.00394	CcSEcCtD
Glycopyrrolate—Pain—Capecitabine—esophageal cancer	0.00264	0.00394	CcSEcCtD
Glycopyrrolate—Constipation—Capecitabine—esophageal cancer	0.00264	0.00394	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—esophageal cancer	0.00263	0.00393	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Capecitabine—esophageal cancer	0.00254	0.00379	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00252	0.00376	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—esophageal cancer	0.00248	0.00371	CcSEcCtD
Glycopyrrolate—Urticaria—Capecitabine—esophageal cancer	0.00245	0.00366	CcSEcCtD
Glycopyrrolate—Abdominal pain—Capecitabine—esophageal cancer	0.00244	0.00364	CcSEcCtD
Glycopyrrolate—Body temperature increased—Capecitabine—esophageal cancer	0.00244	0.00364	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—esophageal cancer	0.00244	0.00364	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00238	0.00355	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—esophageal cancer	0.00231	0.00345	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—esophageal cancer	0.0023	0.00343	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—esophageal cancer	0.00228	0.0034	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Capecitabine—esophageal cancer	0.00227	0.00339	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—esophageal cancer	0.00225	0.00336	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—esophageal cancer	0.00223	0.00333	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—esophageal cancer	0.00222	0.00331	CcSEcCtD
Glycopyrrolate—Asthenia—Capecitabine—esophageal cancer	0.00221	0.0033	CcSEcCtD
Glycopyrrolate—Pruritus—Capecitabine—esophageal cancer	0.00218	0.00326	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—esophageal cancer	0.00214	0.0032	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—esophageal cancer	0.00208	0.0031	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—esophageal cancer	0.00204	0.00305	CcSEcCtD
Glycopyrrolate—Dizziness—Capecitabine—esophageal cancer	0.00204	0.00304	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—esophageal cancer	0.00202	0.00302	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00198	0.00296	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—esophageal cancer	0.00198	0.00295	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—esophageal cancer	0.00196	0.00293	CcSEcCtD
Glycopyrrolate—Vomiting—Capecitabine—esophageal cancer	0.00196	0.00293	CcSEcCtD
Glycopyrrolate—Rash—Capecitabine—esophageal cancer	0.00194	0.0029	CcSEcCtD
Glycopyrrolate—Dermatitis—Capecitabine—esophageal cancer	0.00194	0.0029	CcSEcCtD
Glycopyrrolate—Headache—Capecitabine—esophageal cancer	0.00193	0.00288	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—esophageal cancer	0.00189	0.00282	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00188	0.0028	CcSEcCtD
Glycopyrrolate—Nausea—Capecitabine—esophageal cancer	0.00183	0.00273	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—esophageal cancer	0.00182	0.00272	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—esophageal cancer	0.00181	0.00271	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—esophageal cancer	0.00181	0.00271	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—esophageal cancer	0.00169	0.00252	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—esophageal cancer	0.00165	0.00246	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—esophageal cancer	0.00162	0.00242	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—esophageal cancer	0.00152	0.00227	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—esophageal cancer	0.00146	0.00218	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—esophageal cancer	0.00145	0.00216	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—esophageal cancer	0.00145	0.00216	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—esophageal cancer	0.00144	0.00215	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—esophageal cancer	0.00136	0.00204	CcSEcCtD
Glycopyrrolate—CHRM4—Signaling Pathways—ELMO1—esophageal cancer	0.000382	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—AKAP13—esophageal cancer	0.000373	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—GNG7—esophageal cancer	0.000371	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—GNG7—esophageal cancer	0.00037	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	0.000366	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ELMO1—esophageal cancer	0.000366	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—EP300—esophageal cancer	0.00036	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.00036	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL2—esophageal cancer	0.000359	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000358	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—AKAP13—esophageal cancer	0.000358	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—WWOX—esophageal cancer	0.000357	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—WWOX—esophageal cancer	0.000356	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000355	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—WWOX—esophageal cancer	0.000353	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ADH1B—esophageal cancer	0.000347	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000345	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PDE4D—esophageal cancer	0.000342	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.00034	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FKBP1A—esophageal cancer	0.000339	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000338	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000337	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	0.000336	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000334	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000334	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—ANXA1—esophageal cancer	0.000333	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—WIF1—esophageal cancer	0.000332	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TYMP—esophageal cancer	0.000332	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—WIF1—esophageal cancer	0.000331	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	0.00033	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00033	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—WIF1—esophageal cancer	0.000328	0.000994	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PDE4D—esophageal cancer	0.000327	0.000991	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000327	0.00099	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000326	0.000987	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000325	0.000986	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—GNG7—esophageal cancer	0.000325	0.000984	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000324	0.000983	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.000323	0.000978	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000323	0.000977	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000321	0.000973	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000317	0.000961	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000316	0.000958	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000315	0.000953	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000313	0.000948	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—GNG7—esophageal cancer	0.000311	0.000943	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000307	0.000929	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000306	0.000926	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—XIAP—esophageal cancer	0.000304	0.000922	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000304	0.00092	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000303	0.000917	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000303	0.000917	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TPI1—esophageal cancer	0.0003	0.000909	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTO1—esophageal cancer	0.0003	0.000909	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.0003	0.000908	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000295	0.000895	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000295	0.000892	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000292	0.000884	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—XIAP—esophageal cancer	0.000292	0.000883	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000291	0.000881	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.00029	0.000878	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000288	0.000872	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CTNNA1—esophageal cancer	0.000288	0.000872	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALDOB—esophageal cancer	0.000288	0.000872	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000287	0.00087	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000287	0.000869	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL2—esophageal cancer	0.000286	0.000867	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000286	0.000866	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000284	0.000861	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000283	0.000858	CbGpPWpGaD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000282	0.000855	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000281	0.000852	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000277	0.000839	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CTNNA1—esophageal cancer	0.000276	0.000835	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CRABP1—esophageal cancer	0.000275	0.000832	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL2—esophageal cancer	0.000274	0.00083	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PSME1—esophageal cancer	0.000267	0.00081	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PSME2—esophageal cancer	0.000267	0.00081	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ANXA1—esophageal cancer	0.000266	0.000806	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GNG7—esophageal cancer	0.000261	0.000791	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SST—esophageal cancer	0.000259	0.000784	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000258	0.000781	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000258	0.000781	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.000257	0.000778	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PSME1—esophageal cancer	0.000256	0.000776	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PSME2—esophageal cancer	0.000256	0.000776	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ANXA1—esophageal cancer	0.000255	0.000772	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000254	0.000771	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000252	0.000765	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—GHRL—esophageal cancer	0.000252	0.000764	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH3—esophageal cancer	0.000252	0.000764	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000252	0.000763	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000252	0.000762	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000251	0.00076	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000249	0.000753	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FBXW7—esophageal cancer	0.000248	0.000752	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SST—esophageal cancer	0.000248	0.000751	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000245	0.000741	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	0.000242	0.000732	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—GHRL—esophageal cancer	0.000242	0.000732	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	0.000238	0.00072	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000233	0.000705	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000232	0.000704	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000232	0.000702	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.00023	0.000698	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.00023	0.000697	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.00023	0.000696	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000229	0.000695	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000227	0.000689	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH2—esophageal cancer	0.000226	0.000686	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000219	0.000664	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000218	0.000662	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ENO1—esophageal cancer	0.000218	0.000661	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000218	0.000661	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	0.000217	0.000656	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000216	0.000655	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PSME1—esophageal cancer	0.000215	0.000651	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PSME2—esophageal cancer	0.000215	0.000651	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000205	0.000622	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000205	0.00062	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000203	0.000614	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFBR2—esophageal cancer	0.000201	0.000608	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000194	0.000588	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000194	0.000586	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000193	0.000585	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000192	0.000583	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	0.000192	0.000582	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000192	0.000581	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000191	0.000577	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SMAD4—esophageal cancer	0.00019	0.000576	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000185	0.000562	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	0.000182	0.000551	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.00018	0.000546	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.00018	0.000546	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.00018	0.000544	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.00018	0.000544	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000179	0.000544	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000179	0.000542	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000178	0.000539	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000178	0.000539	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.000177	0.000537	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000175	0.000529	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000174	0.000528	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000174	0.000527	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000172	0.000522	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.00017	0.000515	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.00017	0.000515	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.00017	0.000514	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.00017	0.000514	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.000168	0.000509	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.000168	0.000509	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000167	0.000507	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.000167	0.000505	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000165	0.0005	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—esophageal cancer	0.000159	0.000482	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HIF1A—esophageal cancer	0.000155	0.000471	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000153	0.000463	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000153	0.000462	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000152	0.000461	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.000151	0.000456	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	0.000149	0.000451	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KDR—esophageal cancer	0.000149	0.00045	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KDR—esophageal cancer	0.000142	0.000431	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	0.00014	0.000424	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	0.000135	0.00041	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	0.000135	0.000409	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	0.000134	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	0.000134	0.000405	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	0.000128	0.000388	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	0.000128	0.000387	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	0.000127	0.000385	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	0.000126	0.000383	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	0.000125	0.000378	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	0.000122	0.000368	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	0.00012	0.000362	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000119	0.000361	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000114	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—esophageal cancer	0.000114	0.000344	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—esophageal cancer	0.000109	0.00033	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	0.000108	0.000328	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	0.000106	0.000322	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	0.000105	0.000318	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	0.000104	0.000317	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	0.000104	0.000314	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	0.000103	0.000313	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CREBBP—esophageal cancer	0.000102	0.000309	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	0.000102	0.000309	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KDR—esophageal cancer	0.0001	0.000304	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KDR—esophageal cancer	9.99e-05	0.000303	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KDR—esophageal cancer	9.9e-05	0.0003	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	9.44e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	9.41e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCND1—esophageal cancer	9.4e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	9.32e-05	0.000282	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—esophageal cancer	9.14e-05	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	9.09e-05	0.000275	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCND1—esophageal cancer	9e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	8.7e-05	0.000264	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EP300—esophageal cancer	8.65e-05	0.000262	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	8.56e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	8.54e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	8.45e-05	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	8.41e-05	0.000255	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	8.39e-05	0.000254	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—esophageal cancer	8.36e-05	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	8.31e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EP300—esophageal cancer	8.28e-05	0.000251	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	8.04e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	8.02e-05	0.000243	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	7.94e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—esophageal cancer	7.67e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—esophageal cancer	7.64e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—esophageal cancer	7.57e-05	0.000229	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—esophageal cancer	7.54e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—esophageal cancer	7.37e-05	0.000223	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	7.3e-05	0.000221	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	7.28e-05	0.000221	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—esophageal cancer	7.22e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	7.21e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	7.17e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	7.15e-05	0.000217	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	7.08e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—esophageal cancer	7.06e-05	0.000214	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—EP300—esophageal cancer	6.95e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	6.4e-05	0.000194	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCND1—esophageal cancer	6.34e-05	0.000192	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCND1—esophageal cancer	6.32e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCND1—esophageal cancer	6.25e-05	0.000189	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—esophageal cancer	6.19e-05	0.000188	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	6.13e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	6.13e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	6.11e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	6.05e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—esophageal cancer	5.93e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EP300—esophageal cancer	5.83e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EP300—esophageal cancer	5.81e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EP300—esophageal cancer	5.76e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—esophageal cancer	5.14e-05	0.000156	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—esophageal cancer	5.08e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—esophageal cancer	5.07e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—esophageal cancer	5.02e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—esophageal cancer	4.97e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—esophageal cancer	4.95e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—esophageal cancer	4.91e-05	0.000149	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	4.31e-05	0.000131	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	4.3e-05	0.00013	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	4.26e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—esophageal cancer	4.17e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—esophageal cancer	4.16e-05	0.000126	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—esophageal cancer	4.12e-05	0.000125	CbGpPWpGaD
